InnoCan Pharma Corporation
INNO
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.53% | 43.76% | 39.81% | 38.52% | 28.91% |
| Total Receivables | 76.12% | 14.56% | 83.42% | 17.68% | -19.52% |
| Inventory | -34.31% | -28.58% | -2.14% | 13.53% | 89.87% |
| Prepaid Expenses | 7.46% | -71.12% | -77.18% | -89.33% | -80.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 152.97% | 288.33% | 115.00% | 72.26% | 31.93% |
| Total Current Assets | 14.09% | 16.32% | 27.26% | 20.18% | 34.44% |
|
|
|||||
| Total Current Assets | 14.09% | 16.32% | 27.26% | 20.18% | 34.44% |
| Net Property, Plant & Equipment | -23.89% | -21.19% | -18.03% | -16.41% | -16.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.63% | 15.86% | 26.63% | 19.66% | 33.43% |
|
|
|||||
| Total Accounts Payable | 27.03% | -67.42% | -40.10% | -62.68% | 65.18% |
| Total Accrued Expenses | 53.56% | -- | -- | -- | 3.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -54.55% |
| Total Finance Division Other Current Liabilities | -75.34% | -7.97% | -7.14% | -55.08% | -19.58% |
| Total Other Current Liabilities | -75.34% | -7.97% | -7.14% | -55.08% | -19.58% |
| Total Current Liabilities | -39.45% | 11.65% | 10.60% | -39.27% | -11.99% |
|
|
|||||
| Total Current Liabilities | -39.45% | 11.65% | 10.60% | -39.27% | -11.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.10% | 68.99% | 62.54% | -9.32% | -12.37% |
|
|
|||||
| Common Stock & APIC | 3.88% | 4.84% | 2.43% | 3.13% | 7.80% |
| Retained Earnings | -3.22% | -9.29% | -4.57% | -1.86% | -5.55% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.36% | -25.19% | -12.85% | 13.84% | 25.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.36% | -25.19% | -12.85% | 13.84% | 25.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 42.21% | 55.28% | 104.36% | 270.47% | 555.48% |
| Total Equity | 17.30% | -4.45% | 10.73% | 46.34% | 60.10% |
|
|
|||||